Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Citigroup has recently reduced Illumina Inc (ILMN) stock to Neutral rating, as announced on December 11, 2024, according to Finviz. Earlier, on November 12, 2024, Morgan Stanley had resumed the stock ...

Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $144.22 which represents a slight increase of $7.53 or 5.51% from the prior close of $136.69. The stock opened at $137 and touched a ...

In a report released today, Tejas Savant from Morgan Stanley maintained a Hold rating on Illumina (ILMN – Research Report), with a price target ...

It is worth considering Illumina (ILMN), which belongs to the Zacks Medical - Biomedical and Genetics industry. When looking at the last two reports, this genetic testing tools company has ...

We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, we are going to take a look ...

Among the largest underlying components of IJH, in trading today Williams Sonoma Inc (Symbol: WSM) is off about 0.5%, Illumina Inc (Symbol: ILMN) is up about 2.3%, and EMCOR Group, Inc. (Symbol ...

Buying $100 In ILMN: If an investor had bought $100 of ILMN stock 20 years ago, it would be worth $3,290.99 today based on a ...

Claro Advisors LLC lessened its holdings in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 17.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the ...